We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFBC icon
2376
Preferred Bank
PFBC
$1.25B
$90K ﹤0.01%
1,323
+1,131
+589% +$77.4K
RUSHB icon
2377
Rush Enterprises Class B
RUSHB
$6.06B
$90K ﹤0.01%
2,720
-547
-17% -$17.7K
UNF icon
2378
Unifirst Corp
UNF
$5.24B
$90K ﹤0.01%
523
-1,378
-72% -$230K
CCF
2379
DELISTED
Chase Corporation
CCF
$90K ﹤0.01%
1,153
+372
+48% +$30.5K
FRG
2380
DELISTED
Franchise Group, Inc.
FRG
$90K ﹤0.01%
2,558
-7,177
-74% -$277K
ML
2381
DELISTED
MoneyLion Inc.
ML
$90K ﹤0.01%
+2,263
New +$120K
SRRA
2382
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$90K ﹤0.01%
1,636
-535
-25% -$28.1K
BRC icon
2383
Brady Corp
BRC
$4.54B
$89K ﹤0.01%
1,894
+1,607
+560% +$73.9K
BROS icon
2384
Dutch Bros
BROS
$8.96B
$89K ﹤0.01%
2,798
-3,478
-55% -$143K
MED icon
2385
Medifast
MED
$135M
$89K ﹤0.01%
492
+364
+284% +$65.1K
NATR icon
2386
Nature's Sunshine
NATR
$277M
$89K ﹤0.01%
8,319
+6,454
+346% +$89.7K
TGTX icon
2387
TG Therapeutics
TGTX
$7.52B
$89K ﹤0.01%
20,872
+6,109
+41% +$38.1K
TR icon
2388
Tootsie Roll Industries
TR
$2.97B
$89K ﹤0.01%
2,843
-19,953
-88% -$603K
B
2389
DELISTED
Barnes Group Inc.
B
$89K ﹤0.01%
2,855
+2,420
+556% +$84.2K
GOEV
2390
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$89K ﹤0.01%
104
+71
+215% +$125K
BCC icon
2391
Boise Cascade
BCC
$2.96B
$88K ﹤0.01%
1,473
+1,021
+226% +$75.3K
FBP icon
2392
First Bancorp
FBP
$4.42B
$88K ﹤0.01%
6,874
+3,149
+85% +$43.1K
HTGC icon
2393
Hercules Capital
HTGC
$3.21B
$88K ﹤0.01%
+6,518
New +$102K
PFS icon
2394
Provident Financial Services
PFS
$3.17B
$88K ﹤0.01%
3,949
-2,459
-38% -$55K
USPH icon
2395
US Physical Therapy
USPH
$1.24B
$88K ﹤0.01%
811
+653
+413% +$69.3K
RPT
2396
Rithm Property Trust
RPT
$96M
$88K ﹤0.01%
1,525
+202
+15% +$12.1K
OIIM
2397
DELISTED
02Micro International
OIIM
$88K ﹤0.01%
23,763
+414
+2% +$1.51K
AHRT
2398
AH Realty Trust
AHRT
$503M
$87K ﹤0.01%
6,822
+5,853
+604% +$79.6K
FLGT icon
2399
Fulgent Genetics
FLGT
$524M
$87K ﹤0.01%
1,604
+591
+58% +$32.5K
FSV icon
2400
FirstService
FSV
$6.27B
$87K ﹤0.01%
713
-5,694
-89% -$717K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.